QBRI-HSCI Symposium

Register by clicking here.

Please join us for a symposium on type 1 diabetes presented by the Harvard Stem Cell Institute (HSCI) and Qatar Biomedical Research Institute (QBRI), focused on the latest advances in beta cell differentiation, cell replacement therapy, and autoimmune protection.

8:00-8:15 | WELCOME 
Larry Stanton, with remarks by Doug Melton and Omar El-Agnaf 

8:15-8:55
Evolving role for beta cell replacement in Type I diabetes 
Jim Markmann, MD, PhD
Claude E. Welch Professor of Surgery, Massachusetts General Hospital 

8:55-9:10
Navigating beta cell differentiation via genome-wide loss-of-function screening
Adrian Veres, PhD | HSCI Trainee
Postdoctoral Research Fellow, Harvard University 

9:10-9:55
Towards a robust manufacturing process for autologous iPSC-based therapies.
Ruud Hulspas, PhD
Director Process Development, Dana-Farber Cancer Institute 

9:55-10:20 | BREAK 

10:20-11:00
Genome-wide in vivo CRISPR screen in the study of pancreatic beta cell protection against autoimmune destruction in T1D
Peng Yi, PhD
Assistant Investigator and Co-Director, Genome Editing Core, Joslin Diabetes Center 

11:00-11:40
Immune Barriers to Beta Cell Replacement
Jason Gaglia, MD, MMSc
Director of Hood Center for the Prevention of Childhood Diabetes, Joslin Diabetes Center 

11:40-11:50 | WRAP UP + THANK YOU
Larry Stanton